ADC Therapeutics axes lead solid tumor drug after phase 1 setback, pivots to preclinical programs

0

07.11.2024 16:25

Fiercebiotech.com

ADC Therapeutics axes lead solid tumor drug after phase 1 setback, pivots to preclinical programs ntaylor Thu, 11/07/2024 - 08:25